Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashour, F. A.
Right arrow Articles by Hanson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashour, F. A.
Right arrow Articles by Hanson, M.
(Chest. 1968;53:413-420.)
© 1968 American College of Chest Physicians

Myocardial Sarcoidosis

F. A. Bashour M.D., F.C.C.P.1; Thomas McConnell M.D.1; Walter Skinner M.D.1; and Maurice Hanson M.D.1

1 Institute of Cardiac and Pulmonary Diseases, Methodist Hospital, and the Departments of Medicine and Pathology, The University of Texas Southwestern Medical School

Primary myocardial sarcoidosis has been reported in 45 cases. The disease resulted in a protean clinical manifestation: conduction disturbance, cardiac arrhythmias and congestive heart failure occurred in this order.

Steroid therapy, when used early in the course of the disease, is believed to be beneficial in reversing the cardiac lesion.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American College of Chest Physicians.